Metropolis Healthcare Limited has reported a strong financial performance for the year ended March 31, 2026, with significant revenue and profit growth. The Board of Directors has declared a 2nd Interim Dividend of INR 1/- per equity share. Furthermore, the company announced the appointment of Deloitte Haskins & Sells Chartered Accountants LLP as its new Statutory Auditors and a key leadership transition for Dr. Nilesh Shah, who will move to an advisory role.
Annual Financial Performance
Metropolis Healthcare has concluded the financial year ending March 31, 2026, on a strong note. On a consolidated basis, the company reported total income of INR 1,67,143.03 lakhs for the fiscal year, a significant rise from INR 1,34,631.60 lakhs in the previous year. The consolidated profit for the year attributable to owners reached INR 19,001.74 lakhs, compared to INR 14,496.83 lakhs in the prior year. Earnings per share (EPS) for the fiscal year stood at INR 9.19.
Dividend Declaration
Reflecting the company’s robust financial health and commitment to shareholder value, the Board has declared a 2nd Interim Dividend of INR 1/- per equity share with a face value of INR 2/-. The record date for this payout is set for Tuesday, May 19, 2026, with payment scheduled within 30 days of the declaration.
Strategic Appointments and Transitions
As part of its long-term governance strategy, the company is set to transition its statutory audit mandate. Following the conclusion of the second term of B S R & Co. LLP, the Board has recommended the appointment of Deloitte Haskins & Sells Chartered Accountants LLP. This appointment is subject to shareholder approval at the upcoming 26th Annual General Meeting and will cover a tenure of five consecutive years, extending through the conclusion of the 31st Annual General Meeting.
Senior Management Update
The company also announced a change in its senior management structure. Dr. Nilesh Shah will transition from his full-time role as President – Internal Assurance to an advisory capacity, effective May 14, 2026. Dr. Shah will step down from his classification as a Senior Management Personnel effective from the close of business hours on May 13, 2026.
Source: BSE
